EMPAMUST-M

Empagliflozin 12.5 mg + Metformin 500 mg SR Tablets is a prescription combination medicine used as part of the management of type 2 diabetes mellitus in adults. It contains two complementary medicines—empagliflozin and sustained-release (SR) metformin—that work through different mechanisms to help maintain healthy blood glucose levels.
**Empagliflozin** belongs to a class of medicines known as sodium-glucose co-transporter-2 (SGLT2) inhibitors. It works by reducing the reabsorption of glucose by the kidneys, allowing excess glucose to be eliminated from the body through urine.
**Metformin SR** belongs to the biguanide class of antidiabetic medicines. It primarily works by reducing glucose production by the liver and improving the body's sensitivity to insulin. The sustained-release formulation is designed to release metformin gradually.
### Key Benefits
* Helps control elevated blood glucose levels in adults with type 2 diabetes.* Combines two complementary mechanisms of action in one tablet.* May help improve overall glycemic control when used along with appropriate diet and exercise.* Sustained-release metformin provides prolonged release of the medicine.
### Important Information
This medicine should be taken only as directed by a healthcare professional. It is generally used together with a healthy diet and regular physical activity. The dosage and timing should be followed according to the prescribed treatment plan.
Common side effects may include increased urination, thirst, nausea, diarrhea, or stomach discomfort. Empagliflozin may also increase the risk of genital or urinary tract infections and dehydration. Seek medical advice if you experience unusual weakness, persistent vomiting, difficulty breathing, severe abdominal discomfort, or other concerning symptoms.
This medicine is intended for **type 2 diabetes** and should not be used as a substitute for insulin in people with type 1 diabetes unless specifically directed by a specialist.